Table 3.
Echocardiographic parameters in the non-cardiotoxic group
| Variables | Baseline | End | 6 m. | 9 m. | P1 | P2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LVEF | 62.46 ± 4.87 | 62.19 ± 4.85 | 61.60 ± 4.81 | 60.40 ± 5.10 | 0.829 | 0.171 | ||||||||
| LVGLS | -21.94 ± 1.25 | -21.76 ± 1.26 | -21.64 ± 1.22 | -21.30 ± 1.33 | 0.657 | 0.068 | ||||||||
| SPAP | 13.50 ± 3.59 | 14.77 ± 3.59 | 14.97 ± 4.06 | 15.46 ± 3.86 | 0.225 | 0.057 | ||||||||
| RV-S | 13.96 ± 1.44 | 13.42 ± 1.50 | 13.25 ± 1.47 | 13.21 ± 1.72 | 0.108 | 0.084 | ||||||||
| TAPSE | 1.87 ± 0.18 | 1.90 ± 0.16 | 1.87 ± 0.15 | 1.81 ± 0.11 | 0.990 | 0.230 | ||||||||
| FAC | 45.25 ± 5.68 | 44.83 ± 5.38 | 44.10 ± 5.42 | 44.19 ± 5.72 | 0.743 | 0.785 | ||||||||
| RV EDV | 89.02 ± 9.02 | 89.79 ± 8.77 | 92.79 ± 8.94 | 93.21 ± 9.38 | 0.175 | 0.108 | ||||||||
| RV ESV | 42.67 ± 6.55 | 42.88 ± 6.65 | 44.85 ± 6.69 | 45.48 ± 7.27 | 0.394 | 0.181 | ||||||||
| RV EF | 52.17 ± 4.68 | 52.37 ± 4.65 | 51.77 ± 4.42 | 51.87 ± 4.74 | 0.975 | 0.989 | ||||||||
| RV FWLS | -25.23 ± 1.63 | -25.09 ± 1.62 | -24.95 ± 1.66 | -24.66 ± 1.81 | 0.842 | 0.356 | ||||||||
| RV GLS | -23.39 ± 0.85 | -23.31 ± 0.85 | -23.20 ± 0.87 | -22.98 ± 1.03 | 0.753 | 0.123 | ||||||||
P1: Baseline values compared with 6 months
P2: Baseline values compared with 9 months
LVEF: left ventricle ejection fraction, LVGLS: left ventricle global longitudinal strain, SPAP: systolic pulmonary artery pressure, RV-S: right ventricle systolic wave, TAPSE: Tricuspid annular plane systolic excursion, FAC: fractional area change, RV EDV: right ventricle end-diastolic volume, RV ESV: right ventricle end-systolic volume, RV EF: right ventricle ejection fraction, RVFWLS: right ventricular free wall longitudinal strain, and RVGLS: right ventricular global longitudinal strain